Non-alcoholic fatty liver disease in pediatric type 2 diabetes: metabolic and histologic characteristics in 38 subjects

Diabetes - GeneralType 2 DiabetesObesity and Bariatric Surgery

Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study

Diabetologia.

Eriksson JW, Lundkvist P, Jansson PA, Johansson L, Kvarnström M, Moris L, Miliotis T, Forsberg GB, Risérus U, Lind L, Oscarsson J

doi: 10.1007/s00125-018-4675-2.

Diabetes - GeneralType 2 Diabetes

Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis

Diabetes Care.

Mantovani A, Byrne CD, Bonora E, Targher G

doi: 10.2337/dc17-1902.

Type 2 DiabetesLipids

Association between non-alcoholic fatty liver disease and impaired cardiac sympathetic/parasympathetic balance in subjects with and without type 2 diabetes-The Cooperative Health Research in South Tyrol (CHRIS)-NAFLD sub-study

Nutr Metab Cardiovasc Dis

Targher G, Mantovani A, Grander C, Foco L, Motta B, Byrne CD, Pramstaller PP, Tilg H

doi: 10.1016/j.numecd.2021.08.037

Diabetes - GeneralType 2 Diabetes

Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes

Metabolism.

Käräjämäki AJ, Bloigu R, Kauma H, Kesäniemi YA, Koivurova OP, Perkiömäki J, Huikuri H, Ukkola O

doi: 10.1016/

Type 2 Diabetes

SGLT2 inhibitors: the future for treatment of type 2 diabetes mellitus and other chronic diseases

Diabetologia.

Wanner C, Marx N

doi: 10.1007/s00125-

Type 2 DiabetesPediatric Diabetes

Pediatric Quality of Life Inventory (PedsQL) 3.2 Diabetes Module for youth with Type 2 diabetes: reliability and validity

Diabet Med.

Varni JW, Delamater AM, Hood KK, Raymond JK, Chang NT, Driscoll KA, Wong JC, Yi-Frazier JP, Grishman EK, Faith MA, Corathers SD, Kichler JC, Miller JL, Doskey EM, Aguirre VP, Heffer RW, Wilson DP; Pediatric Quality of Life Inventory 3.2 Diabetes Module Testing Study Consortium

doi: 10.1111/dme.13841.

Diabetes - GeneralType 2 DiabetesGlycemic Control

Fatty Acid Metabolic Remodelling During Type 2 Diabetes Remission After Bariatric Surgery

Diabetes.

Grenier-Larouche T, Carreau AM, Geloën A, Frisch F, Biertho L, Marceau S, Lebel S, Hould FS, Richard D, Tchernof A, Carpentier AC

doi: 10.2337/db17-0414.

Type 2 DiabetesPediatric Diabetes

Elevated Serum Uric Acid Is Associated With Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents With Type 2 Diabetes: An Observational Analysis From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study

Diabetes Care.

Bjornstad P, Laffel L, Lynch J, El Ghormli L, Weinstock RS, Tollefsen SE, Nadeau KJ; TODAY Study Group

doi: 10.2337/dc18-2147.

Type 2 Diabetes

Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes

Diabetes Obes Metab.

Gastaldelli A, Repetto E, Guja C, Hardy E, Han J, Jabbour SA, Ferrannini E

doi: 10.1111/dom.13907.

Related content